E-LIB Suche - Ergebnisse für: Rodriguez-Pinto, Ignasi - Sprache EN

Search for persons X

Sorted by: Relevance

Sorted by: Year

1

Description of a novel splice site variant in UBA1 gene cau..:

Ospina Cardona, Daniela ; Rodriguez-Pinto, Ignasi ; Iosim, Sonia...
Rheumatology. , 2024

Link: https://doi.org/10.1093/..

2

What we know and what we don't know about catastrophic anti..:

Rodriguez-Pintó, Ignasi ; Espinosa, Gerard ; Cervera, Ricard
Rheumatology. 63 (2024) SI - p. SI46-SI53 , 2024

Link: https://doi.org/10.1093/..

3

Cardiac involvement in the catastrophic antiphospholipid sy..:

Pons, Isaac ; Jeréz, Alba ; Espinosa, Gerard...
Seminars in Arthritis and Rheumatism. 66 (2024) - p. 152439 , 2024

Link: https://doi.org/10.1016/..

4

Exposure to different occupational chemicals and clinical p..:

Freire, Mayka ; Sopeña, Bernardo ; González-Quintela, Arturo...
Autoimmunity Reviews. 23 (2024) 5 - p. 103542 , 2024

Link: https://doi.org/10.1016/..

5

Optimizing Noninvasive Vagus Nerve Stimulation for Systemic..:

Contreras, Ivan ; Navarro-Otano, Judith ; Rodríguez-Pintó, Ignasi...
JMIR Research Protocols. 12 (2023) - p. e48387 , 2023

Link: https://doi.org/10.2196/..

6

Pulmonary involvement in catastrophic antiphospholipid synd..:

Ponce, Ana ; Rodríguez-Pintó, Ignasi ; Espinosa, Gerard...
Seminars in Arthritis and Rheumatism. 63 (2023) - p. 152265 , 2023

Link: https://doi.org/10.1016/..

7

Spanish cohort of VEXAS syndrome: clinical manifestations, ..:

Mascaro, Jose Manuel ; Rodriguez-Pinto, Ignasi ; Poza, Gabriela...
Annals of the Rheumatic Diseases. 82 (2023) 12 - p. 1594-1605 , 2023

Link: https://doi.org/10.1136/..

8

Eculizumab use in catastrophic antiphospholipid syndrome (C..:

López-Benjume, Brenda ; Rodríguez-Pintó, Ignasi ; Amigo, Mary Carmen...
Autoimmunity Reviews. 21 (2022) 4 - p. 103055 , 2022

Link: https://doi.org/10.1016/..

9

The clinical significance of low complement levels in patie..:

Ponce, Ana ; Rodríguez-Pintó, Ignasi ; Basauli, José M...
Lupus. , 2022

Link: https://doi.org/10.1177/..

10

Cost-effectiveness analysis of treatments for the first epi..:

Quintana-López, Gerardo ; Rodríguez-Pintó, Ignasi ; Maldonado-Cañón, Kevin...
Lupus. 31 (2022) 2 - p. 194-201 , 2022

Link: https://doi.org/10.1177/..

11

Standardized incidence ratios and risk factors for cancer i..:

Carbonell, Cristina ; Marcos, Miguel ; Guillén-del-Castillo, Alfredo...
Autoimmunity Reviews. 21 (2022) 10 - p. 103167 , 2022

Link: https://doi.org/10.1016/..

12

Comparison of non-criteria antiphospholipid syndrome with d..:

Pires da Rosa, Gilberto ; Ferreira, Ester ; Sousa-Pinto, Bernardo...
Frontiers in Immunology. 13 (2022) - p. , 2022

Link: https://doi.org/10.3389/..

13

Importance of the determination of enzymatic activity in th..:

Abbasi, Adrián ; Batllori, Marta ; Gil-Sáez, Francisco Jose...
Medicina Clínica (English Edition). 159 (2022) 6 - p. 283-286 , 2022

Link: https://doi.org/10.1016/..

14

Catastrophic antiphospholipid syndrome presenting with aort..:

Moroni, Luca ; Righini, Paolo ; Ramirez, Giuseppe A...
Lupus. 30 (2021) 6 - p. 1005-1009 , 2021

Link: https://doi.org/10.1177/..

15

A new molecular classification to drive precision treatment..:

Soret, Perrine ; Le Dantec, Christelle ; Desvaux, Emiko...
Nature Communications. 12 (2021) 1 - p. , 2021

Link: https://doi.org/10.1038/..

1-15